Editorial: Acromegaly: What constitutes optimal therapy?

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 443-445

  Frohman, L A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; OCTREOTIDE; GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; EDITORIAL; GENE TRANSFER; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; PRIORITY JOURNAL; TRANSSPHENOIDAL SURGERY; TREATMENT PLANNING; BLOOD; METABOLISM; SECRETION;

ACROMEGALY; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I;

EID: 0030075687     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.443     Document Type: Editorial

References (0)